Medical Intelligence signs a letter of intent with France Telecom toward global strategic Columba service partnership in France

    QUEBEC CITY, March 14 /CNW/ - Medical Intelligence Technologies Inc.
(TSX-V: MIZ) announces it has signed a letter of intent with France Telecom,
initiating discussions to establish a global strategic partnership leading to
the commercialization of the Columba service that prevents wandering by
Alzheimer patients. The service relies on the Columba bracelet developed by
Medical Intelligence and the services provided jointly with France Telecom
under its brand Orange. France's institutional and consumer markets are both
covered by this draft agreement.
    Under the terms of the letter of intent, France Telecom is to place firm
orders for Columba bracelets, and the target for this commercialization effort
is to sell several thousands Columba units.
    The parties will also discuss potential European expansion of the
geographic area covered in the draft agreement.
    "Since the Columba bracelet was introduced to France's consumer market,
governments and institutions have shown an increasing level of interest in our
product," declared Louis Massicotte, President of Medical Intelligence. "At
this stage of our Company's evolution, it is mutually beneficial to rally our
sales force with that of France Telecom to efficiently meet market demand. In
France alone, more than a million people are stricken with cognitive
impairment and are forced to remain home due to insufficient space in
retirement communities."


    Medical Intelligence is the leader in the personal tele-security
industry, integrating information and telecommunications technologies to the
healthcare sector. The firm designs portable medical devices for the benefit
of people having health or safety concerns. Based in Quebec City, Medical
Intelligence Technologies also has an office in Paris, where it commercializes
the Columba bracelet with cell phone operator Orange and in Madrid partnering
with Telefonica Moviles Espana. For further information, visit or


    The Medical Intelligence Technologies-developed Columba phone-bracelet to
prevent disappearance among Alzheimer's patients is a definitive solution to
the problems of walking and straying often associated with Alzheimer's
disease. Combining "handsfree" portable telephone, GPS positioning system and
an intelligent alert system that detects any straying outside of a safe zone,
the Columba device is able to quickly locate the person who has exited this
pre-defined zone, thereby reducing the risks associated with Alzheimer's
patients' walking habits.


    Any statement in this press release that does not relate directly and
exclusively to historical facts can be considered a forward-looking statement.
Such statements reflect the intentions, plans, expectations and beliefs of
Medical Intelligence Technologies, and are subject to risks, uncertainties and
other factors that are largely beyond the Company's control, to the extent
that actual results may differ significantly from those contemplated by such
statements. Medical Intelligence Technologies neither intends nor is required
to update or revise such forward-looking statements based on new information
or future events, or for any other reason.

    The TSX Venture Exchange assumes no responsibility for the content or
    accuracy of this press release

    %SEDAR: 00020559EF

For further information:

For further information: Johanne Lépine, Media Relations, Torchia
Communications, (514) 288-8290, ext 234,; Investor
relations: Eric Bouchard, The Equicom Group Inc., (514) 844-7997,; For information: Quebec City, Jean Brouillard
Communications, (418) 682-6111,

Organization Profile

Medical Intelligence Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890